USP22 and melanoma: Moreover, they found deletion of the deubiquitinating protease ubiquitin specific peptidase 22 (USP22) in melanoma cells decreased the efficacy of T cell-mediated killing in vitro and in vivo, while USP22 overexpression enhanced tumor-cell sensitivity to T cell-mediated killing (Li M. et al., 2021).